MedTrace Logo

Anterior Advantage With KINCISE

NCT04191733 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2023-09-15

Study results available
· View outcomes & findings →

Summary

This is a post-market prospective, 1:1 randomized, multicenter non-inferiority study to compare the femoral broaching time for THA with the Anterior Advantage approach with KINCISE vs. without KINCISE. Follow-up will continue through 24 weeks post-op.

Conditions

Interventions

DEVICE

KINCISE(TM) Surgical Automated System

Uncemented Total Hip Arthroplasty via Anterior Approach with and without the KINCISE(TM) Surgical Automated System

Sponsors & Collaborators

  • DePuy Orthopaedics

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-28
Primary Completion
2022-07-13
Completion
2022-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04191733 on ClinicalTrials.gov